膀胱癌循环肿瘤细胞的检测及临床应用研究进展  

Advance in circulating tumor cell detection and its clinical application in bladder cancer

作　　者：戴利和 马重[1] 曾蜀雄[1] 黄健[2] 许传亮[1] 

机构地区：[1]第二军医大学附属长海医院泌尿外科,上海200433 [2]中山大学孙逸仙纪念医院泌尿外科

出　　处：《临床泌尿外科杂志》2016年第2期176-179,共4页Journal of Clinical Urology

摘　　要：膀胱癌是我国常见的恶性肿瘤,复发和转移是常见死因。循环肿瘤细胞作为无创实时肿瘤检测指标,在恶性肿瘤诊疗中具有潜在的应用价值。因此,我们回顾了近十年来膀胱癌循环肿瘤细胞的研究,简述了其检测方法的发展情况以及在膀胱癌诊断、疗效及预后监测方面的应用价值。Bladder cancer is one of the most common malignant tumors in China. Its high morality is due to metastasis and recurrence. Circulating tumor cell （CTC） is widely acknowledged as a non-invasive, real-time bio- marker for several malignant tumors, so we should pay attention to its latent value in diagnosing and treating ma- lignant tumors. After reviewing the study of bladder cancer CTC in recent ten years, we sketch out its detective method and application value in diagnosis, prognosis and curative effect monitoring of bladder cancer.

关 键 词：循环肿瘤细胞 膀胱癌 诊断 预后 

分 类 号：R737.14[医药卫生—肿瘤]